ÂÜÀòÂÒÂ×

Colin Platt is scientist II, bioanalysis, working on pre-clinical research and development as part of the Pharmacology and Toxicology team at Verve Therapeutics. Dr. Platt received his B.A. in Chemistry from Williams College and his Ph.D. in Biomedical Science from Harvard University, where his research focused on large-scale combinatorial genetic screening of miRNAs for the development of cardioprotective and/or cardiac-regenerative gene therapies. Prior to joining Verve, he served as a postdoctoral fellow in the Cardiovascular Research Center at Massachusetts General Hospital.